Medication Adherence
Conditions
Brief summary
This is a randomized clinical trial evaluating the educational program called My Interventional Drug Eluting Stent Educational App (MyIDEA) that is a pilot at two sites.
Interventions
DEVICEMyIDEA
An educational tablet app that is customized to the patient based on the data in the Electronic Health Record.
Sponsors
Cook County Health
National Institutes of Health (NIH)
National Institute on Aging (NIA)
National Institute of Nursing Research (NINR)
University of Illinois at Chicago
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. received a drug eluting stent during a Percutaneous Coronary Intervention (PCI) during a hospitalization for the PCI procedure, 2. were greater than 50 years old (funding agency requirement), 3. spoke and understood English.
Exclusion criteria
1. inability to give informed consent 2. allergy to aspirin
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of study design engaging elderly patients in novel tablet based education. | 3 months | Would research participants enroll and follow up in a study of tablet based education. Do patients think they know everything? Would patients enrolled in the control arm still follow up in the study? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Medication adherence | 3 months | A measure of Pharmacy days covered for DAPT medication. The patients after recieving a Drug Eluting Stent need to adhere to Dual Antiplatlet Therapy (DAPT) to prevent restenosis of the stent. PDC is a calculation of the DAPT which is Aspirin and an ADP receptor antagonist. As aspirin is over the counter, the pharmacy does not have a record of purchase so the PDC was calculated for the ADP receptor antagonis. |
Outcome results
None listed